Navigation Links
Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
Date:2/12/2008

bo, as measured by the International Prostate Symptom Score (IPSS), the primary endpoint. Secondary endpoints included improvements of maximum urine flow and quality of life. As expected, the most common side effects seen in the two studies greater than 2% were retrograde ejaculation (reduced semen) and dizziness.

Silodosin is highly uroselective for the alpha (1A) receptors located in the prostate and bladder neck. Blocking these receptors relaxes the smooth muscles, resulting in an improvement in urine flow and a reduction in BPH symptoms. The selective binding of silodosin to the alpha (1A) receptors is substantially greater than the binding to the cardiovascular-associated alpha (1B) receptors and thereby maximizes target organ activity while minimizing the potential for blood pressure effects.

The compound was originally developed by Kissei Pharmaceutical Co., Ltd., in Japan and licensed to Watson for the United States, Canada and Mexico. Kissei successfully launched Urief(R) (silodosin) in Japan in May of 2006 at a twice daily dosing of 4mg. Urief(R) is marketed in cooperation with Daiichi Sankyo Pharmaceutical Co., Ltd.

BPH, or an enlarged prostate, is a condition found only in men and is characterized by a non-cancerous enlargement of the prostate gland. Symptoms of BPH include urinary difficulty, urinary frequency and an inability to complete bladder emptying. The number of BPH patients has been increasing with the expansion of the elderly population. In the United States, BPH affects more than half of men in their 60's and as many as 90 percent of men by the age of 85. According to IMS data, BPH symptoms were the primary reason patients visited their urologists in 2006.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watso
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
2. Watson Launches Generic Biaxin(R) XL
3. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
4. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
5. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
6. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
7. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
8. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
9. Inverseon Announces Positive Phase IIa Asthma Study
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... researchers with EDP Biotech Corporation (EDP) have captured ... a simple blood test to detect early-stage colon ... its pre-clinical trials for the ColoMarker(TM) assay, EDP ... and all aspects of its use. Via ... cancer in its earliest, most curable stages. ,, ...
(Date:12/15/2009)... Tenn., Dec. 15 Cumberland Pharmaceuticals ... announced new top-line results for a patient ... Oral Solution, a prescription laxative packaged as a ... forms. ,, Kristalose is the only prescription-strength laxative ... period, 50 patients with a recent diagnosis of ...
(Date:12/15/2009)... Dec. 15 Today,s New ... "Plan for Kidney Drugs Spurs Division," illustrates an ... in kidney patients continuing to be deprived of ... Medicare program limit. ,, As Congress is poised ... preserve the lives of transplant kidney recipients, behind-the-scenes ...
Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 1Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 4Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 5Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 6Chimerix to Present at Two Upcoming Investor Conferences 6195 1Chimerix to Present at Two Upcoming Investor Conferences 6195 2Behavior modification could ease concerns about nanoparticles 10701 1Behavior modification could ease concerns about nanoparticles 10701 2
... and Specific Molecular Structures Needed for siRNA ... ... Silence Therapeutics plc,(AIM:SLN) Europe,s leading RNAi-focused biotechnology company, today,comments on ... via TLR3" Mark E.,Kleinman, et. al., and Molecules and Cells(2) ...
... Data from five studies sponsored,by Ortho Biotech ... Kidney,Foundation (NKF) 2008 Spring Clinical Meetings from April ... (Epoetin alfa)., The data include studies that ... and darbepoetin alfa (DARB), evaluate medical costs,related to ...
Other Medicine Technology:Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 2Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 3Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 2Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 3Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 5Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 6
(Date:12/15/2009)... it,s still too early to say that ... TUESDAY, Dec. 15 (HealthDay News) -- Common chemicals ... to the abnormal growth of breasts in boys, ... in a prominent medical journal for pediatricians, adds ... phthalates, whose safety has been questioned by some ...
(Date:12/15/2009)... a leading provider of secure USB devices, today launches SafeConsole ... flash drive. The software is designed to provide better usability ... of new features and range of licensing options. , ... ... -- BlockMaster ( www.blockmastersecurity.com ) a leading provider of secure ...
(Date:12/15/2009)... goes up within a week of getting news, ... -- Emotional stress can put newly diagnosed prostate ... and suicide, a new study has found. , ... with prostate cancer between 1961 and 2004. Of ... event within a year of cancer diagnosis and ...
(Date:12/15/2009)... Accelify is proud to announce the addition of David ... serve as Director of Development in the State of ... Advisors. ,, David Tokofsky was elected to ... in June 1995. As the Board Member for District ... from Northeast Los Angeles through East Los Angeles to ...
(Date:12/15/2009)... Health Technologies, Inc. (OTC Bulletin Board: VHGI) confirmed ... subsidiary of VHGI) has appointed two key industry ... with bringing the Treasure Gulch and Zero Gold ... Additionally, the company is informing interested shareholders and ... Live Investor Town Hall Meeting so that investors ...
Breaking Medicine News(10 mins):Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 3Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 4Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 5
... 25 Musketeer Group, Inc. and Coalition,America, Inc. ... unique,repricing solution for Musketeer customers. The partnership streamlines ... greater,administrative and medical claim savings. CAI,s integration with ... claims,as well as expedited adjudication of repriced claims. ...
... American Society,for Therapeutic Radiology and Oncology has published ... Gynecologic Cancers. The brochure,provides women coping with a ... radiation therapy and their treatment options, as well,as ... how to care for,themselves while undergoing treatment. ...
... Diego, September 25, 2007 Some people are caught ... own abuse as a child and continuing into perpetration ... it is important to understand how childhood experiences are ... published in the October issue of the American Journal ...
... in The Netherlands have developed a method of accurately ... to have their disease recur after surgery and who ... , Led by Professor Rob Tollenaar at Leiden University ... The Netherlands Cancer Institute, they have analysed for the ...
... Wash., Sept. 25 Cardiac Science,Corporation (Nasdaq: ... advanced cardiac monitoring,and defibrillation products, today applauded ... lay rescuers from the Pittsburgh school district ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ) Cardiac ...
... Mass., Sept. 25 CutisPharma, Inc. has ... as its preferred,vendor for unit-of-use compounding kits. ... Shoppe(R) and Medicap Pharmacy(R) franchisees the ability ... pharmacies already providing the,service, to increase the ...
Other Medicine News:Health News:Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators 2Health News:Updated Brochure on Gynecologic Cancer Treatments Now Available 2Health News:Victims of child maltreatment more likely to perpetrate youth violence, intimate partner violence 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 2Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 4Health News:CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits 2Health News:CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits 3
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. A shoulder drop-away can also be used with our Stretchy-back and cummmberbund aprons. Shoulder pads and hangi...
Open armhole design with Velcro release enables removal without compromising sterile field. Loops attached at shoulders for proper hanging & storage...
This apron provides full protection all the way around. Extra wide Velcro strips provide many adjustments and a secure fit....
Unique criss-cross strapping distributes weight evenly over the torso for ultimate comfort and flexibility. Fully adjustable 2 inch belt and buckle for easy front closure....
Medicine Products: